Trial intelligence / Profile preview

Tolerability of Levalbuterol HFA vs Racemic Albuterol HFA in Asthma

NCT00685022Phase 2Completed

Sponsor
Sumitomo Pharma America
Start
Jun 2003
Primary completion
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levalbuterol in asthma, sponsored by Sumitomo Pharma America. Started Jun 2003; status: completed.

02

Drugs

levalbuterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00685022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00685022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call